Drug Profile
Diepalrestat choline - BioNevia/NeuroMax
Alternative Names: BNV-222; Choline cocrystal of epalrestat; Choline diepalrestat; NM-IA-001Latest Information Update: 10 Oct 2018
Price :
$50
*
At a glance
- Originator Bionevia Pharmaceuticals
- Developer BioNevia Pharmaceuticals; NeuroMax
- Class Small molecules; Thiazolidines
- Mechanism of Action Aldehyde reductase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II/III Diabetic neuropathies